#MedSky🧪#Cancerimmunotherapy #Cancerbiology CD8+ #Tcells are end effectors of #cancerimmunity. Most forms of effective #cancerimmunotherapy involve CD8+ T cell effector function.
October 11, 2023 at 11:08 AM
#MedSky🧪#Cancerimmunotherapy #Cancerbiology CD8+ #Tcells are end effectors of #cancerimmunity. Most forms of effective #cancerimmunotherapy involve CD8+ T cell effector function.
#Medsky🧪 #oncosky ICIs are widely used for #cancerimmunotherapy but only a fraction of patients respond & gut bacteria impact the efficacy of ICIs in fighting tumors outside of the gut. Certain strains of commensal #gutbacteria promote antitumor responses to ICIs …
The gut microbiome and cancer response to immune checkpoint inhibitors
www.jci.org/articles/vie...
Review @jclinical-invest.bsky.social
www.jci.org/articles/vie...
Review @jclinical-invest.bsky.social
February 4, 2025 at 7:36 PM
#Medsky🧪 #oncosky ICIs are widely used for #cancerimmunotherapy but only a fraction of patients respond & gut bacteria impact the efficacy of ICIs in fighting tumors outside of the gut. Certain strains of commensal #gutbacteria promote antitumor responses to ICIs …
MedSky🧪 #Immunotherapy #Gutmicrobiome & #Cancerimmunotherapy The #gutmicrobiota influences anti-tumor #immunity & can induce or inhibit response to #immunecheckpointinhibitors
March 28, 2024 at 10:55 AM
MedSky🧪 #Immunotherapy #Gutmicrobiome & #Cancerimmunotherapy The #gutmicrobiota influences anti-tumor #immunity & can induce or inhibit response to #immunecheckpointinhibitors
#Medsky🧪 #IDSky #immunosky #Oncosky #publichealth The study explores the long-term implications of #COVID19pandemic on #cancerimmunotherapy.
🔑
-Persistent 🦠 spike protein exposure can sustain inflammatory pathways, disrupting the tumor microenvironment & compromising #immunotherapy efficacy.
🔑
-Persistent 🦠 spike protein exposure can sustain inflammatory pathways, disrupting the tumor microenvironment & compromising #immunotherapy efficacy.
Post COVID-19 pandemic Inflammatory Insights into Cancer: Consequences for immunotherapy
The COVID-19 pandemic has reshaped the landscape of global health, revealing novel interactions between infectious diseases and chronic conditions suc…
www.sciencedirect.com
December 7, 2025 at 7:48 AM
#Medsky🧪 #IDSky #immunosky #Oncosky #publichealth The study explores the long-term implications of #COVID19pandemic on #cancerimmunotherapy.
🔑
-Persistent 🦠 spike protein exposure can sustain inflammatory pathways, disrupting the tumor microenvironment & compromising #immunotherapy efficacy.
🔑
-Persistent 🦠 spike protein exposure can sustain inflammatory pathways, disrupting the tumor microenvironment & compromising #immunotherapy efficacy.
#Medsky🧪 #IDsky #oncosky #immunosky #publichealth The advent of mRNA vaccines has revolutionized prophylactic & therapeutic strategies across multiple disease areas, from #infectiousdiseases to #cancerimmunotherapy. While highly effective in protecting against #
June 23, 2025 at 1:25 PM
#Medsky🧪 #IDsky #oncosky #immunosky #publichealth The advent of mRNA vaccines has revolutionized prophylactic & therapeutic strategies across multiple disease areas, from #infectiousdiseases to #cancerimmunotherapy. While highly effective in protecting against #
#Medsky🧪 #oncosky #pharmasky #Cancerimmunotherapy Properties of @fda.gov approved small molecule protein kinase inhibitors: A 2024 update & Targeted Drug Therapy for NSCLC .
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
Owing to the dysregulation of protein kinase activity in many diseases including cancer, this enzyme family has become one of the most important drug …
www.sciencedirect.com
February 1, 2025 at 10:25 AM
#Medsky🧪 #oncosky #pharmasky #Cancerimmunotherapy Properties of @fda.gov approved small molecule protein kinase inhibitors: A 2024 update & Targeted Drug Therapy for NSCLC .
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
MedSky🧪#CancerResearch #Cancerimmunotherapy the intratumoral #microbiota signatures vary between #neoadjuvantchemotherapy- #Immunotherapy (NACI) responders & nonresponders among patients with ESCC. The responders contained an abundance of tumor-resident Streptococcus compared with nonresponders.
September 16, 2023 at 5:04 AM
MedSky🧪#CancerResearch #Cancerimmunotherapy the intratumoral #microbiota signatures vary between #neoadjuvantchemotherapy- #Immunotherapy (NACI) responders & nonresponders among patients with ESCC. The responders contained an abundance of tumor-resident Streptococcus compared with nonresponders.